Introduction
Acute necrotizing ulcerative gingivitis (ANUG) is a rare, severe infection of the gum tissue, affecting less than 1% of the population. ANUG presents as an acute, painful, and destructive ulceration and inflammation of the interdental gum tissue.[1][2] Although the prevalence of this disease is low, it is of high clinical significance as it represents the most severe condition associated with the dental biofilm. If left untreated, ANUG can lead to very rapid tissue destruction, necrotizing ulcerative periodontitis, and even cancrum oris (noma), which is commonly fatal.[3] Treatment of ANUG is determined on a case-by-case basis, often employing a multifactorial approach tailored to the extent of the infection and the patient's tolerance.[4]
Etiology
Register For Free And Read The Full Article
Search engine and full access to all medical articles
10 free questions in your specialty
Free CME/CE Activities
Free daily question in your email
Save favorite articles to your dashboard
Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Etiology
ANUG is typically an opportunistic bacterial infection caused by spirochetes or gram-negative bacteria.[1] Results from a study identified spirochetes and predominantly gram-negative bacteria, including Bacteroides intermedius and Fusobacterium spp., as the most common causes.[4][5] Furthermore, results from another study primarily implicated species of Treponema, Selenomonas, Fusobacterium, and Prevotella intermedia.[6]
Epidemiology
Historians have documented cases of ANUG since the fourth century BCE. Most reports from the ancient world came from fighting troops, and studies of ANUG in the modern world continue to highlight soldiers as a prominent demographic affected by the disease.[1][7] ANUG is more common in younger individuals, particularly severely malnourished children and young adults with HIV infection.[1][8] In the United States, ANUG appears to occur primarily in White individuals.[9] Results from prospective clinical studies have also found psychological stress, immunosuppression, and tobacco use to be strongly associated epidemiologically with the development of ANUG.[10]
Pathophysiology
Many physiologic factors play a central role in the development of ANUG, including psychological stress, malnutrition, insufficient sleep, use of alcohol or tobacco, poor oral hygiene, preexisting gingivitis, and HIV infection. These factors have been shown to impair the host immune response, which facilitates bacterial virulence. Psychological stress reduces gingival microcirculation and salivary flow; it also increases adrenocortical secretion, thereby modifying the function of polymorphonuclear leukocytes (PMNs) and lymphocytes and altering the efficacy of the host immune response. In addition, psychological stress can influence the patient's behavior and mood, leading to poor oral hygiene, malnutrition, and increased tobacco use, further increasing their susceptibility to infection.[6] Similarly, a poor diet increases histamine levels and capillary permeability in the gingiva, thereby reducing PMN chemotaxis.[6]
Histopathology
The clinical appearance of ANUG reflects its histopathology.[6] Four distinct layers have been described. Most superficial is a bacterial area within a fibrous mesh composed of epithelial cells, leukocytes, and various bacteria, including rods, fusiforms, and spirochetes. Deep to that layer lies a neutrophil-rich zone with a higher density of leukocytes, spirochetes, and other bacterial cells. Next lies a necrotic zone containing disintegrated cells, spirochetes, and fusiform bacteria. The deepest layer contains spirochete infiltration.[6] Often, microbiological testing does not provide relevant diagnostic information, as the microbial profile of ANUG can also be typical of healthy gingiva, gingivitis, and periodontitis.[6] A few case series have demonstrated the utility of Gram staining to support the diagnosis, which is otherwise purely clinical.[5]
History and Physical
ANUG is primarily a clinical diagnosis, making the history and physical examination essential. Three core findings establish the diagnosis: sudden-onset oral pain, gingival bleeding, and the characteristic necrosis and ulceration of the interdental papillae.[1][10] Additional features may include lymphadenopathy; malaise; a strong, fetid odor on the breath; and a gingival pseudomembrane.
Several predisposing factors are thought to contribute to the development of ANUG.[6] Poor oral hygiene and compromised immune function, particularly in individuals with HIV infection, are strongly linked to the diagnosis of ANUG.[6] Nutritional deficiencies, inadequate living conditions, and significant psychological stress have also been frequently noted as contributing risk factors.[1][6]
Evaluation
As discussed in the History and Physical section, ANUG is primarily a clinical diagnosis based on a detailed history and physical examination. There are 3 essential clinical components required to confirm the diagnosis: sudden-onset oral pain, gingival bleeding, and the characteristic necrosis and ulceration of the interdental papillae. A Gram stain of the gingival tissue supports the diagnosis; however, this test is not always performed and is not required.[5]
Treatment / Management
The treatment of ANUG should be approached in successive stages: acute-phase management, treatment of any preexisting conditions, management of disease sequelae, and transition to the supportive or maintenance phase.[6] Treatment of the acute phase aims to halt tissue destruction and to control the patient's discomfort. Gentle ultrasonic debridement is used for superficial gingival plaques and calculi, in conjunction with localized oxygen therapy directed at necrotic lesions.[6] The use of 0.12% chlorhexidine gluconate mouth rinse should be considered, with a suggested regimen of twice-daily use for 30 days.[11] (B3)
Systemic antimicrobials are considered in the acute phase in cases with poor response to debridement or with symptoms of systemic involvement, including fever, malaise, and vomiting.[6] Metronidazole (250 mg 3 times daily) is a common first-choice agent due to its activity against anaerobes. Penicillin, tetracyclines, clindamycin, amoxicillin, and amoxicillin-clavulanate have been shown to produce acceptable results and are considered on a case-by-case basis. Results from a study of oral penicillin, for example, showed significant clinical improvement within 3 to 6 days.[5] Although oral antibiotics are beneficial, topical antimicrobials are not recommended. The high bacterial density in the tissue impairs the ability to achieve adequate drug concentrations. Significantly, antifungal agents should be added for patients with immunosuppression who are undergoing antibiotic therapy.[6](B3)
After the acute phase has been controlled, treatment of any preexisting conditions, such as chronic gingivitis, should be initiated. This stage involves procedural prophylaxis, such as scaling and root planing, and the establishment of oral hygiene maintenance methods with the patient.[11] Gingivectomy or gingivoplasty procedures can treat any superficial craters.[6] Predisposing factors, including smoking, poor sleep hygiene, and stress, should also be addressed.(B3)
The main goals of the maintenance phase are to promote patient adherence to oral hygiene practices and to control any predisposing factors.[6] If proper maintenance is not carried out, relapses are likely to occur. Treating ANUG requires a multifactorial approach that includes superficial debridement, oral hygiene instruction, use of antimicrobial mouthwash, and, potentially, oral antibiotics, as well as initiation of a comprehensive prophylaxis plan that provides for root planing and management of predisposing factors.[4]
Differential Diagnosis
ANUG may be mistaken for other infectious or inflammatory conditions. Considerations for a differential diagnosis should include bacterial causes, such as gonococcal or streptococcal gingivitis, and viral causes, such as acute herpetic gingivostomatitis and infectious mononucleosis, in addition to mucocutaneous conditions such as desquamative gingivitis, multiforme erythema, and pemphigus vulgaris.[6] Clinicians should consider ANUG in individuals with HIV, even if their CD4+ T-lymphocyte counts have remained stable.
Pertinent Studies and Ongoing Trials
While numerous studies have examined suspected risk factors for ANUG, research on the condition remains limited. Approximately two-thirds of the observed studies on ANUG have been surveys or case reports, with the remainder being case-control studies. Only a few longitudinal and population-based studies are available, most of which are conducted in high-risk populations. Furthermore, the results of many of these studies pertain to gingivitis in general rather than ANUG specifically. Other existing studies are based on small numbers or on case histories alone, without including control subjects, which leaves much to be desired in this field of research. However, the extremely low incidence of ANUG in the population severely limits the feasibility of most longitudinal studies at this time.[9]
Prognosis
Appropriate multifactorial management of ANUG usually prevents disease progression, and ulcer healing can be expected within a few days after initiating treatment. However, untreated ANUG can rapidly deteriorate into potentially fatal conditions such as sepsis, necrotizing ulcerative periodontitis, and cancrum oris (noma).[1]
Complications
Acute necrotizing ulcerative gingivitis may result in severe tissue destruction, including necrotizing periodontitis, necrotizing stomatitis, and cancrum oris (noma), which is often fatal. Developing the knowledge necessary to identify and manage ANUG promptly is essential for both adult and pediatric clinicians.[12]
Deterrence and Patient Education
Healthy gums are essential to overall health. Maintaining good oral hygiene is the most effective way to prevent destructive periodontal diseases, such as ANUG. Routine practices help maintain gum health and prevent disease, including twice-daily brushing, daily flossing or interdental cleaning, and regular dental visits.[13] Conditions such as HIV infection, diabetes, and cancer can reduce the body's ability to fight infection, which can increase the risk of developing gum disease. Other factors that can affect the gums include medications such as anticonvulsants and some blood pressure medications, in addition to tobacco use and hormonal changes, including pregnancy. For this reason, it is vital for pregnant individuals and those meeting any of these criteria to see a dentist regularly.[13]
Enhancing Healthcare Team Outcomes
Effectively managing ANUG requires a coordinated effort across the interprofessional healthcare team. Because presentations may range from classic diagnostic features to vague or incomplete symptoms, dentists, physicians, advanced practitioners, nurses, pharmacists, and other health professionals must share a unified strategy for prompt identification of potentially necrotizing gingival disease, even when criteria are only partially met. Understanding the roles of each member of the interprofessional team enhances patient safety and quality of care.
Dentists and dental hygienists provide definitive diagnosis, comprehensive periodontal assessment, and targeted interventions tailored to individual patient needs. Physicians and advanced practitioners play a key role in identifying systemic risk factors, screening for immunocompromising conditions, and ensuring timely referral to dental professionals. Nurses contribute by assessing oral discomfort, documenting visible gingival changes, reinforcing preventive behaviors, and coordinating follow-up. Pharmacists support patient-centered care by reviewing medications for potential contributors to xerostomia or immunosuppression, counseling patients on safe use of oral health products, and guiding appropriate antimicrobial therapy when indicated.
Collaborative strategies improve outcomes by emphasizing prevention, communication, and structured workflows. A meta-analysis identified several critical actions: communicating the significance of gingival bleeding as an early indicator of disease; implementing universal periodontal screening across points of care; understanding both the value and limitations of self-directed oral health products; and reducing barriers to timely, evidence-based professional care.[14] Consistent application of these shared practices enhances team performance and advances a coordinated, patient-centered approach to reducing morbidity, thereby improving long-term oral health and patient well-being.
References
Mizrahi Y. [NUG--necrotizing ulcerative gingivitis: a review]. Refu'at ha-peh veha-shinayim (1993). 2014 Jul:31(3):41-7, 62 [PubMed PMID: 25219100]
Haas AN, Stewart S, Susin C, Albandar JM. Necrotizing Periodontal Diseases: Epidemiology, Clinical Features, and Etiopathogenesis. Journal of periodontal research. 2025 Sep 23:():. doi: 10.1111/jre.70028. Epub 2025 Sep 23 [PubMed PMID: 40985215]
Herrera D, Alonso B, de Arriba L, Santa Cruz I, Serrano C, Sanz M. Acute periodontal lesions. Periodontology 2000. 2014 Jun:65(1):149-77. doi: 10.1111/prd.12022. Epub [PubMed PMID: 24738591]
Dufty J, Gkranias N, Donos N. Necrotising Ulcerative Gingivitis: A Literature Review. Oral health & preventive dentistry. 2017:15(4):321-327. doi: 10.3290/j.ohpd.a38766. Epub [PubMed PMID: 28761942]
Kaplan D. Acute necrotizing ulcerative tonsillitis and gingivitis (Vincent's infections). Annals of emergency medicine. 1981 Nov:10(11):593-5 [PubMed PMID: 7316264]
Level 3 (low-level) evidenceMalek R, Gharibi A, Khlil N, Kissa J. Necrotizing Ulcerative Gingivitis. Contemporary clinical dentistry. 2017 Jul-Sep:8(3):496-500. doi: 10.4103/ccd.ccd_1181_16. Epub [PubMed PMID: 29042743]
Dufty J, Gkranias N, Petrie A, McCormick R, Elmer T, Donos N. Prevalence and treatment of necrotizing ulcerative gingivitis (NUG) in the British Armed Forces: a case-control study. Clinical oral investigations. 2017 Jul:21(6):1935-1944. doi: 10.1007/s00784-016-1979-9. Epub 2016 Nov 9 [PubMed PMID: 27830369]
Level 2 (mid-level) evidenceHu J, Kent P, Lennon JM, Logan LK. Acute necrotising ulcerative gingivitis in an immunocompromised young adult. BMJ case reports. 2015 Sep 16:2015():. doi: 10.1136/bcr-2015-211092. Epub 2015 Sep 16 [PubMed PMID: 26376700]
Level 3 (low-level) evidenceMelnick SL, Roseman JM, Engel D, Cogen RB. Epidemiology of acute necrotizing ulcerative gingivitis. Epidemiologic reviews. 1988:10():191-211 [PubMed PMID: 3066627]
Rowland RW. Necrotizing ulcerative gingivitis. Annals of periodontology. 1999 Dec:4(1):65-73; discussion 78 [PubMed PMID: 10863376]
Martos J, Ahn Pinto KV, Feijó Miguelis TM, Cavalcanti MC, César Neto JB. Clinical treatment of necrotizing ulcerative gingivitis: a case report with 10-year follow-up. General dentistry. 2019 May-Jun:67(3):62-65 [PubMed PMID: 31199747]
Level 3 (low-level) evidenceMarty M, Palmieri J, Noirrit-Esclassan E, Vaysse F, Bailleul-Forestier I. Necrotizing Periodontal Diseases in Children: A Literature Review and Adjustment of Treatment. Journal of tropical pediatrics. 2016 Aug:62(4):331-7. doi: 10.1093/tropej/fmw005. Epub 2016 Mar 10 [PubMed PMID: 26966241]
American Dental Association (ADA) Division of Science. For the patient. Keeping your gums healthy. Journal of the American Dental Association (1939). 2015 Apr:146(4):A46. doi: 10.1016/j.adaj.2015.01.021. Epub [PubMed PMID: 25819663]
Tonetti MS, Chapple IL, Jepsen S, Sanz M. Primary and secondary prevention of periodontal and peri-implant diseases: Introduction to, and objectives of the 11th European Workshop on Periodontology consensus conference. Journal of clinical periodontology. 2015 Apr:42 Suppl 16():S1-4. doi: 10.1111/jcpe.12382. Epub [PubMed PMID: 25683242]
Level 3 (low-level) evidence